Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5637.5576.05 (+1.37 %)

PREV CLOSE ( ) 5561.50

OPEN PRICE ( ) 5413.10

BID PRICE (QTY) 5630.00 (5)

OFFER PRICE (QTY) 5639.00 (7)

VOLUME 412

TODAY'S LOW / HIGH ( )5413.10 5646.00

52 WK LOW / HIGH ( )4498.9 5867.5

NSE5636.5081 (+1.46 %)

PREV CLOSE( ) 5555.50

OPEN PRICE ( ) 5555.50

BID PRICE (QTY) 5636.00 (2)

OFFER PRICE (QTY) 5637.00 (1)

VOLUME 19066

TODAY'S LOW / HIGH( ) 5555.50 5652.00

52 WK LOW / HIGH ( )4491.65 5868

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-08 1973

Management Info

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

16Dec Alkem Laboratories informs about chang
Pursuant to Regulation 30 of the SEBI LODR Regulations, Alkem Laboratori..

12Dec Alkem Laboratories informs about news
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

10Dec Malta Medicines Authority concludes GM
Malta Medicines Authority has concluded GMP inspection at Alkem Laborato..

08Dec Alkem Laboratories informs about chang
Alkem Laboratories has informed that Rakesh Tripathi shall cease to hold..

05Dec Alkem Laboratories informs about discl
Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	7867.3	22808.9
Gross Profit	8007.1	23035.4
Operating Profit	8720.5	26632.6
Net Sales	25420.3	88134.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE) 1748.00 (7.19%)	M.Cap ( in Cr)821.57
Abbott India (BSE) 28110.00 (0.25%)	M.Cap ( in Cr)59751.97
Astrazeneca Pharma I (BSE) 9130.95 (0.76%)	M.Cap ( in Cr)22794.75
Ajanta Pharma (BSE) 2690.05 (2.58%)	M.Cap ( in Cr)33532.72
NGL Fine-Chem (BSE) 1335.00 (4.35%)	M.Cap ( in Cr)824.77

Shareholding Pattern

	PROMOTERS	51.2%
	NON-INSTITUTION	17.4%
	MUTUAL FUNDS/UTI	16.94%
	FI/BANKS/INSURANCE	3.62%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall...	4.49
Motilal Oswal Nifty...	4.47
ICICI Pru Pharma He...	4.01
NJ ELSS Tax Saver S...	3.58
LIC MF Healthcare F...	3.50
ICICI Pru Nifty Pha...	3.36
Nippon India Nifty ...	3.36

Risk Disclosures on Derivatives

Smart Quotes

ALKEM LABORATORIES LTD.